Central IKKβ inhibition prevents air pollution mediated peripheral inflammation and exaggeration of type II diabetes by Liu, Cuiqing et al.
Liu et al. Particle and Fibre Toxicology 2014, 11:53
http://www.particleandfibretoxicology.com/content/11/1/53RESEARCH Open AccessCentral IKKβ inhibition prevents air pollution
mediated peripheral inflammation and
exaggeration of type II diabetes
Cuiqing Liu1,2†, Laura K Fonken2†, Aixia Wang2, Andrei Maiseyeu3, Yuntao Bai2, Tse-Yao Wang2, Santosh Maurya2,
Yi-An Ko4, Muthu Periasamy2, Timothy Dvonch5, Masako Morishita5, Robert D Brook5, Jack Harkema6,
Zhekang Ying3, Bhramar Mukherjee4, Qinghua Sun2, Randy J Nelson2 and Sanjay Rajagopalan3*Abstract
Background: Prior experimental and epidemiologic data support a link between exposure to fine ambient
particulate matter (<2.5 μm in aerodynamic diameter, PM2.5) and development of insulin resistance/Type II diabetes
mellitus (Type II DM). We investigated the role of hypothalamic inflammation in PM2.5-mediated diabetes
development.
Methods: KKay mice, a genetically susceptible model of Type II DM, were assigned to either concentrated PM2.5 or
filtered air (FA) for 4–8 weeks via a versatile aerosol concentrator and exposure system, or administered
intra-cerebroventricular with either IKKβ inhibitor (IMD-0354) or TNFα antibody (infliximab) for 4–5 weeks simultaneously
with PM2.5 exposure. Glucose tolerance, insulin sensitivity, oxygen consumption and heat production were evaluated. At
euthanasia, blood, spleen, visceral adipose tissue and hypothalamus were collected to measure inflammatory cells using
flow cytometry. Standard immunohistochemical methods and quantitative PCR were used to assess targets of interest.
Results: PM2.5 exposure led to hyperglycemia and insulin resistance, which was accompanied by increased
hypothalamic IL-6, TNFα, and IKKβ mRNA expression and microglial/astrocyte reactivity. Targeting the NFκB
pathway with intra-cerebroventricular administration of an IKKβ inhibitor [IMD-0354, n = 8 for each group)], but
not TNFα blockade with infliximab [(n = 6 for each group], improved glucose tolerance, insulin sensitivity, rectified
energy homeostasis (O2 consumption, CO2 production, respiratory exchange ratio and heat generation) and
reduced peripheral inflammation in response to PM2.5.
Conclusions: Central inhibition of IKKβ prevents PM2.5 mediated peripheral inflammation and exaggeration of
type II diabetes. These results provide novel insights into how air pollution may mediate susceptibility to insulin
resistance and Type II DM.
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According to the recently published global burden of
disease statement, among risk factors, indoor and outdoor
air-pollution represents the third and tenth leading causes
of global morbidity and mortality respectively [1]. The
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unless otherwise stated.by particulate matter content, especially particles <2.5 μm in
aerodynamic diameter (PM2.5) [2,3]. Both epidemiologic
studies and experimental evidence support adverse cardio-
metabolic consequences of air-pollution exposure, includ-
ing worsening of whole body insulin sensitivity, promotion
of hepatic endoplasmic reticulum stress, brown adipose
dysfunction, and peripheral inflammation [4-6].
Insulin resistance (IR) is widely believed to evolve as a
consequence of inflammatory signaling in the peripheral
metabolic tissues such as the liver, adipose tissue, skeletal
muscle, and/or the vasculature [7-9]. The central nervousThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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regulator of metabolic control. In diet-induced obesity,
early onset hypothalamic inflammation has been impli-
cated in central resistance to fuel-sensing hormones, loss
of homeostatic control of food intake, and changes in en-
ergy expenditure. These changes in the hypothalamus
have been noted in rodent models, as well as in humans
[10-12]. In time course studies, peripheral inflammation
takes weeks to develop following initiation of a high fat
diet, whereas hypothalamic inflammation occurs rapidly
within 24 hrs and prior to substantial weight gain and
peripheral inflammation [13,14]. Targeting inflammation
in the hypothalamus by the inactivation of IκB kinase or
TNFα blockade protects against defective thermogenesis,
obesity and IR [15,16], suggesting that hypothalamic
dysfunction may precede and mechanistically contribute
to obesity-associated IR and Type II diabetes (Type II
DM). We hypothesized that inhalation of concentrated
PM2.5 would result in hypothalamic inflammation and
exert effects on peripheral inflammation and IR and tested
this hypothesis in a genetically susceptible mouse model






























































































Figure 1 PM2.5 and BC concentration at the study site. A, BC concentra
was labeled under the X-axis with exact date information. B, PM2.5 and BC co
different exposure periods. The mean values of PM2.5/BC concentration were
denotes black carbon.Results
Exposure characteristics
Three batches of KKay mice were exposed by inhalation to
either filtered air (FA) or concentrated ambient PM2.5 dur-
ing three distinct exposure periods which were named as
Exposure 1, Exposure 2, and Exposure 3 for convenience of
description (Figure 1A). During Exposure 1, mice were ex-
posed for 6 h/d, 5 d/wk, 5 weeks or 8 weeks. For Exposure
2, mice were treated (ICV) with infliximab or artificial CSF
through an implanted ICV catheter (see ICV drug infusion
protocol) and exposed for 6 h/d, 5 d/wk, for 5 weeks. For
Exposure 3, mice were treated with IMD-0354 (ICV) or
vehicle (DMSO) and exposed for 6 h/d, 5 d/wk, for 4 weeks.
During the three exposure periods, mean concentra-
tion of PM2.5 was 9.6, 10.7 and 6.3 μg/m
3 in the ambient
air, 2.3, 2.3 and 2.7 μg/m3 in the filtered air chamber,
116.9, 139.5 and 73.6 μg/m3 in the concentrated PM2.5
exposure chamber respectively. This represented 12.2,
13.1 and 11.8-fold concentration over ambient levels
respectively (Figure 1B). For the purposes of conveni-
ence, concentrated ambient PM2.5 exposure is referred


























































posure 2 Exposure 3
tion in the ambient air from Dec. 2011-Nov. 2012. Exposure 1-Exposure 3
ncentration in the filter air, ambient air and concentrated ambient air for
shown above the according bar graphs in different exposure period. BC
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carbon in the ambient air at the site of exposure facility, for
the period Dec. 2011-Nov. 2012. The mean concentration
of black carbon in the PM2.5 was 8.0 and 8.8 μg/m
3 for Ex-
posure 2 and Exposure 3 respectively, about 10-fold higher
than that of ambient air with 0.8 μg/m3 for both exposure
periods (Figure 1B). Mean organ carbon and elemental
carbon concentrations in the PM2.5 for Exposure 3 were
11.5 ± 5.3 μg/m3 and 2.0 ± 0.7 μg/m3 and together repre-
sented 18.9% of concentrated ambient PM2.5 mass.Exaggeration of IR in KKay mice by PM2.5
Since KKay mice are well known to develop abnormalities
in glucose metabolism and progressive IR over 5–10 weeks
[17], we exposed 5-week old KKay mice to PM2.5 for 5 or
8-week periods (Exposure 1) and evaluated them weekly for
glucose and insulin measures. No alteration in body weight
or food intake was observed during the exposure to PM2.5
(data not shown). An increase in fasting blood glucose was
seen within 1-week of exposure to PM2.5, while insulin
levels trended upwards, with the highest values after 6-
week of exposure and significant differences between the
two groups at the 3- and 8-week time-points (Figure 2A).
Corresponding homeostasis model assessment of the IR
index (HOMA-IR) levels were significantly different at the
1-, 3- and 8-week time-points (Figure 2A).PM2.5 exposure induces inflammation in hypothalamus of
KKay mice
Air pollution has been previously shown to cause CNS
inflammation, oxidative stress and pathological alterations









































































































Figure 2 Effect of PM2.5 exposure on glucose homeostasis and hypot
and the HOMA-IR after 6-hr fasting during 8 wks of PM2.5 exposure. B, mRN
wks PM2.5 exposure. *P < 0.05, **P < 0.01, ***P < 0.001 compared to respectithat long term exposure to PM2.5 over 10 months results
in hippocampal pro-inflammatory cytokine expression [20].
Although hypothalamic inflammation is well-documented
in models of diet-induced obesity [10,15,21], its role as a
potential mediator of altered energy and glucose homeosta-
sis in response to air-pollution has not been explored. To
address this question, we examined mRNA encoding in-
flammatory mediators, including cytokines (IL-6, TNFα),
Suppressor of cytokine signaling 3 (SOCS-3), components
of the NFκB pathway (IKKβ and IκB), and microglia/
macrophage (MAC1). In the hypothalamus of mice
exposed to PM2.5, TNFα and IL-6 expression was elevated
after 5-week of exposure to PM2.5 as compared to FA
(Figure 2B). Longer duration (8-week) exposure to PM2.5
elevated TNFα and IL-6 expression, as well as significantly
increased IKKβ expression. There was no difference in the
mRNA levels of other genes (Figure 2B). These results
suggest that even short-term exposure of a few weeks is
sufficient to induce increases in cytokine expression in the
medial basal hypothalamus. To further understand the
mechanisms responsible for inflammation, we assessed
the levels of oxidized 1-palmitoyl-2-arachidonoyl-sn-
glycero-3-phosphocholine (oxPAPC), a prototypic biolo-
gically active oxidized phospholipid in the brains of mice
exposed to PM2.5 and compared these to FA exposed mice.
Ox-PAPC has been previously shown by us and others
to activate NFκB pathways via toll-like receptor path-
ways [22,23]. The level of oxPAPC was elevated in
PM2.5 exposed mice compared to controls (286054 vs.
180579 arbitrary units). When expressed as a % of PAPC,
the PM2.5 exposed animals demonstrated a 2-fold increase





























































































 8-WK Exposure 
halamic inflammation in KKay mice. A, Blood glucose, insulin levels
A levels of inflammation mediators in hypothalamus after 5 wks or 8
ve FA group. n = 6-8 per group.
Figure 3 Representative LC-MS chromatograms showing effect of PM2.5 exposure on oxidized PAPC in brain of mice. Lipid extracts from
brain of mice exposed to FA or PM2.5 were analyzed by HPLC with positive electrospray ionization mass spectrometry operating in multiple reaction
monitoring mode.
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metabolism parameters
Based on the increased hypothalamic TNFα expression
in PM2.5 mice and observations that this may contrib-
ute to changes in peripheral inflammation including
brown adipose tissue dysfunction [24], we hypothesized
that TNFα antagonism may restore peripheral glucose
intolerance and altered thermogenesis following PM2.5
exposure. Mice at age of 5-week were continuously ad-
ministered infliximab (0.2 μg/day) or artificial cerebrospinal
fluid (aCSF) through a minipump connected to a cannula
directed at the lateral ventricle. Minipumps were implanted
1 day prior to initiation of either PM2.5 or FA exposure
(Exposure 2, Figure 1B). As shown in Figure 4A, intra-
cerebroventricular (ICV) infliximab did not influence per-
ipheral glycemia or insulin tolerance in response to PM2.5
exposure; neither did body temperature, body weight differ
between groups (Figure 4B-4C). However food intake was
lowered in the PM-Inflix group compared to PM-CON
both during the exposure period (Figure 4D) or after the
exposure period (Figure 4E).
When analyzing the energy parameters, we used two
different analytical strategies as detailed in the Methods. In
the first analysis, we used the average measure for each
index over time for each mouse and used linear regression.
Using this approach no significant difference in O2consumption, CO2 production, respiratory exchanging ratio
(RER) or heat production was observed in response to
PM2.5 exposure (Table 1). However, infliximab treatment
inhibited heat production in PM2.5 inhaled mice regardless
of phase of day. Using repeated measures analysis (adjusting
for time), much more significant differences were found.
Although only O2 consumption and CO2 production were
inhibited in response to PM2.5 inhalation when the data for
the entire day were used, PM2.5 inhalation additionally
inhibited heat generation during the dark phase (Table 1).
These results indicate a consistency of effect of PM2.5 and
additionally that metabolism itself displays circadian vari-
ation with a higher activity during the dark phase and lower
activity during light phase for rodents. Infliximab treatment
significantly impaired energy homeostasis, as evidenced by
further decreases in O2 consumption, CO2 production,
RER, and heat generation in infliximab-treated mice com-
pared to controls (Table 1).
Central IKKβ inhibition prevents PM2.5-induced disruption
of metabolism
To determine whether upregulated hypothalamic IKK-NF-
κB pathway contributes to PM2.5-exaggarated IR, we
continuously administered IMD-0354, a pharmacological
inhibitor of IKKβ (IKK2) through a minipump connected to




























































































































































Figure 4 Metabolism response to intracerebroventricular infusion of Infliximab in KKay mice exposed to PM2.5. A, GTT and ITT of PM2.5
exposed KKay mice after 5-week treatment with TNFα antibody. B, Average rectal temperatures for mice by the end of 5-week PM2.5 exposure.
C, Body weight of mice during 5-week PM2.5 exposure. D, Average daily food consumption during (D) or after (E) 5-week PM2.5 exposure. P < 0.05
when compared with PM-CON group.
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prior to initiation of either PM2.5 or FA exposure for 4 weeks
(Exposure 3, Figure 1). Consistent with the results from
“exposure 1”, PM2.5 induced abnormal glucose tolerance and
attenuation of whole-body insulin sensitivity, which were
normalized with IMD-0354 treatment (Figure 5A). This
effect was PM2.5 dependent, as IMD-0354 did not further
improve these parameters in the FA group (Figure 5A). No
other difference was shown either in body weight or in food
intake during the exposure period between groups except
for an increase in body weight after 4 weeks PM2.5 exposure
(Figure 5B-C). Taken together, these results suggest that cen-
tral IKKβ inhibition prevents PM2.5-induced abnormalities
in glucose/insulin homeostasis.
To examine whether central IKKβ Inhibition could
improve PM2.5-induced impairment of energy metabol-
ism, we measured O2 consumption, CO2 production,
RER and heat production and analyzed the data withtwo analytical strategies. When repeated measures ana-
lysis was applied, PM2.5 inhalation inhibited energy me-
tabolism, reflected by decreased O2 consumption, CO2
production and heat generation, both in the whole day
phase and in the dark Phase (Figure 6A,B,D). As expected,
ICV IMD-0354 normalized the energy metabolism, evi-
denced by restoration of these parameters (O2 consump-
tion, CO2 production heat generation both in the whole
day phase and in the dark phase) and further increase in
RER in the dark phase, compared with PM2.5-exposed
mice administered vehicle (Figure 6 and Table 2). When
the analysis of average over time followed by linear regres-
sion was applied, O2 consumption, CO2 production and
heat generation were all inhibited in response to PM2.5
inhalation only during the day but not the dark period
(Figure 6A,B,D). No significant difference was observed
between IMD-0354 treated groups and their respective
controls (Figure 6, Table 2).
Table 1 Energy metabolism response to intracerebroventricular infusion of infliximab in KKay mice exposed to PM2.5
Phase Measured
index
Method FA-CON vs PM-CON PM-CON vs PM-Inflix
Estimate SE p-value Estimate SE p-value
Light + Dark O2 Avg −193.125 170.601 0.270 −182.738 170.601 0.296
RM −171.714 66.509 0.010 −184.556 66.509 0.006
CO2 Avg −186.684 197.569 0.355 −248.623 197.569 0.222
RM −159.923 79.478 0.044 −248.577 79.478 0.002
RER Avg −0.001 0.015 0.969 −0.025 0.015 0.113
RM 0.001 0.008 0.899 −0.025 0.008 0.003
Heat Avg −0.020 0.033 0.548 −0.076 0.033 0.030
RM −0.016 0.012 0.204 −0.078 0.012 0.000
Dark O2 Avg −272.695 195.576 0.178 −186.257 195.576 0.352
RM −278.074 85.804 0.001 −186.729 85.804 0.030
CO2 Avg −273.400 234.828 0.257 −289.425 234.828 0.231
RM −280.245 106.432 0.009 −287.488 106.432 0.007
RER Avg −0.002 0.019 0.901 −0.037 0.019 0.062
RM −0.003 0.010 0.753 −0.036 0.010 0.000
Heat Avg −0.035 0.035 0.338 −0.079 0.035 0.036
RM −0.036 0.016 0.022 −0.079 0.016 0.000
O2 consumption, CO2 production, RER and heat production of mice measured by indirect calorimetry over a 24 hrs period (from 10:00 am to 10:00 am the next
day) after 5-week PM2.5 exposure. n = 6.
Avg = analysis performed based on mice averages over cycles. Covariates in the model include PM exposure, treatment group, and the interaction between PM
and treatment group.
RM = analysis with repeated measurements. The correlation structure within mice was assumed to be autoregressive-1. Covariates in the model include PM,
treatment group, PM x treatment interaction, and time.
Mean model using averages over cycles (Avg): E (Y) = b0 + b1PM + b2 Trt + b3 PM*Trt.




































































































Figure 5 Glucose homeostasis response to ICV infusion of IMD-0354 in KKay mice exposed to PM2.5. A, GTT and ITT of PM2.5 exposed
KKay mice after 4-week treatment with IMD-0354. B, Body weight during the 4-week of PM2.5 exposure and IKKβ inhibitor treatment. C, Food
intake during the 4-week of PM2.5 exposure and IKKβ inhibitor treatment. *P < 0.05, ***P < 0.001 compared to FA-CON group; ##P < 0.01 when
compared PM-IMD group with PM-CON group. n = 6-8 per group.
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Figure 6 Energy metabolism response to ICV infusion of IMD-0354 in KKay mice exposed to PM2.5. O2 consumption (A), CO2 production
(B), respiratory exchanging ratio (C) and heat production (D) of mice measured by indirect calorimetry over a 24 hrs period (from 10:00 am to
10:00 am the next day) after 4 wks of PM2.5 exposure and IKKβ inhibitor treatment. When RM (repeated measures adjusting for time) analysis was
applied: ***P < 0.001 compared to FA-CON group; #P < 0.05, ###P < 0.001 when compared PM-IMD group with PM-CON group. When Avg
(the average over time followed by linear regression) was applied, &P < 0.05 compared to FA-CON group. n = 6 per group.
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peripheral inflammation
We next investigated the effect of central IKKβ inhib-
ition on peripheral inflammation induced by PM2.5
exposure. In the present study, we defined monocytes as
side scatter-high, forward scatter-low cells expressing the
myeloid antigen 7/4 (high populations) and high levels of
CD11b but low for the neutrophil marker Gr-1 (Ly6G),
which corresponds to Ly6Chi monocytes and represents
the inflammatory subtype [23,25,26]. We noted a clear
trend (P = 0.0518) of increase in circulating CD11b+Gr-
1low7/4hi cells, the inflammatory subtype in response to
PM2.5 exposure. The levels of CD11b
+Gr-1low7/4hi in
circulation were reduced in mice treated with IMD-0354
ICV (Figure 7A).F4/80+CD11c+ is a macrophages marker and these
cells have been demonstrated to play a pathophysio-
logical role in high-fat diet-induced obesity [27-31]. F4/
80+/CD11c+ cells in visceral adipose tissue (VAT) were
markedly higher in response to PM2.5 exposure, with
the increase being attenuated by IMD-0354 treatment
(Figure 7B). Together with data demonstrating that
PM2.5-mediated monocytes infiltration into VAT is CCR2
dependent [32], these results suggest mechanisms similar
to those involved in diet mediated aggravation of the VAT
infiltration by monocytes via CCR2 dependent pathways
[29]. These results indicate that peripheral inflammation
in blood and adipose tissue in response to PM2.5 is
dependent on CNS inflammation to a considerable
degree.
Table 2 Energy metabolism response to intracerebroventricular infusion of IMD 0354 in KKay mice exposed to PM2.5
Phase Measured
index
Method FA-CON vs PM-CON PM-CON vs PM-IMD
Estimate SE p-value Estimate SE p-value
Light + Dark O2 Avg −370.927 149.129 0.032 331.662 167.254 0.061
RM −371.022 59.968 0.000 335.500 64.236 0.000
CO2 Avg −333.440 127.020 0.025 347.582 181.272 0.070
RM −332.649 62.399 0.000 351.053 76.737 0.000
RER Avg 0.000 0.009 0.985 0.011 0.016 0.473
RM 0.000 0.006 0.989 0.011 0.009 0.205
Heat Avg −1.826 0.722 0.030 1.694 0.855 0.061
RM −1.825 0.303 0.000 1.712 0.336 0.000
Dark O2 Avg −346.732 185.106 0.076 340.550 185.106 0.081
RM −340.496 82.903 0.000 336.695 82.903 0.000
CO2 Avg −372.246 209.234 0.090 414.139 209.234 0.062
RM −359.378 97.723 0.000 406.893 97.723 0.000
RER Avg −0.016 0.017 0.360 0.028 0.017 0.117
RM −0.012 0.010 0.248 0.026 0.010 0.012
Heat Avg −1.781 0.958 0.078 1.809 0.958 0.073
RM −1.743 0.433 0.000 1.786 0.433 0.000
O2 consumption, CO2 production, RER and heat production of mice measured by indirect calorimetry over a 24 hrs period (from 10:00 am to 10:00 am the next day)
after 5-week PM2.5 exposure. n = 6.
Avg = analysis performed based on mice averages over cycles. Covariates in the model include PM exposure, treatment group, and the interaction between PM
and treatment group.
RM = analysis with repeated measurements. The correlation structure within mice was assumed to be autoregressive-1. Covariates in the model include PM,
treatment group, PM x treatment interaction, and time.
Mean model using averages over cycles (Avg): E (Y) = b0 + b1PM + b2 Trt + b3 PM*Trt.
Mean model using repeated measures data (RM): E (Y) = b0 + b1PM + b2 Trt + b3 PM*Trt + b4cycle.
Covariance structure: autoregressive-1.
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hypothalamic inflammation
As depicted in Figure 8A, IMD-0354 reduced IL-6 and
IKKβ expression, both of which were up-regulated by
PM2.5 exposure, but had no effect on TNFα and IκB
expression. Reactive gliosis, identified by the recruitment,
activation, and proliferation of glial cells, such as astrocytes,
NG2 cells, and microglia, in the arcuate nucleus of the
hypothalamus, has been associated with changes in meta-
bolic homeostasis [13]. Thus, we investigated the effects of
PM2.5 exposure and IKKβ inhibition on microglia and
astrocyte reactivity in the arcuate nucleus of the hypothal-
amus. Using anti-Iba1 (ionized calcium binding adaptor
molecule 1), a microglia-specific cytoplasmic marker [33],
we found a 20% increase in microglial number in the
arcuate nucleus of mice exposed to PM2.5 compared to
FA (Figure 8B). Additionally, microglia from PM2.5
mice were larger with a more activated morphology
(Figure 8C). Central IMD-0354 infusion restored both
the number and size of microglia in response to PM2.5
(Figure 8B-C). The effect of PM2.5 on astrocytes was
assessed with GFAP immunostaining. Astrocytes are
abundant throughout the CNS and were apparent in
the arcuate nucleus of all groups. The intensity of GFAPstaining which was elevated among PM2.5 mice was
prevented by treatment with the IKKβ inhibitor (Figure 9).
Chronic high fat feeding results in prolonged inflamma-
tory responses in the CNS, which can cause loss of sensing
in proopiomelanocortin (POMC) neurons [34]. POMC
neurons are critical components of the network regulating
energy balance in mammals and loss of POMC neurons is
associated with development of metabolic syndrome [35].
Therefore we examined evidence of POMC neuronal loss
in the hypothalamus; however, neither PM2.5 exposure nor
drug treatment affected POMC number (data not shown,
P > 0.05).
Discussion
In this paper we demonstrate PM2.5 exposure induces
hypothalamic inflammation in a genetically susceptible
model of Type II DM. The increased cytokine expression
in the hypothalamus was accompanied by evidence of
exacerbation of peripheral glycemia and IR. Increased
levels of oxidized phospholipids in the brain may repre-
sent one possible mechanism that may account for activa-
tion of downstream inflammatory pathways. Central IKKβ
inhibition but not TNFα blockade prevented the effects of


























































































Figure 7 Anti-inflammation in blood and VAT in response to ICV IMD-0354 in KKay mice exposed to PM2.5. A, Representative flow
cytometric dot plots and analysis showing circulating CD11b+Gr-1low7/4hi cells from mice blood at the end of 4-week PM2.5 exposure and IMD-0354
treatment. B, Representative flow cytometric dot plots and analysis showing CD11c+F4/80+ cells from VAT at the end of 4 week PM2.5 exposure and
IMD-0354 treatment. *P < 0.05 compared to FA-CON group, #P < 0.05 when compared PM-IMD group with PM-CON group. n = 6-8 per group.
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http://www.particleandfibretoxicology.com/content/11/1/53abnormal O2 consumption, CO2 production, heat gener-
ation and inhibited the PM2.5-enhanced peripheral inflam-
mation. Importantly, central IKKβ inhibition effectively
reduced IL-6 and reactive gliosis in hypothalamus. In
addition, the consistency of the effect regardless of
location of exposure (urban in exposure 1 vs. near
roadway in exposures 2 and 3) suggests that there
may be no significant differences at least within the
confines of a large urban area, regardless of proximity
to a highway, although our study was not designed to test
these differences.
A number of studies have shown that exposure to PM2.5
is associated with, or lead directly to IR, adiposity, plaque
destabilization, and adverse cardiovascular events, in which
pro-inflammatory and oxidative stress pathways play crit-
ical roles [5,36-40]. In rodent models of diet-induced obes-
ity, increased inflammatory signaling in the mediobasal
hypothalamus occur early and prior to peripheral inflam-
mation and altered energy homeostasis [12,13,41]. These
findings suggest that inflammatory changes in the CNSmay mechanistically contribute to the development of
obesity and IR [15].
The CNS plays a critical role in energy balance with
multiple environmental and internal signals serving as
cues to trigger the requisite behavioral and physiological
response to maintain energy homeostasis. Considerable
progress has been made in elucidating the molecular and
cellular pathways, primarily within the hypothalamus and
hindbrain. In previous studies, we have demonstrated evi-
dence of CNS inflammation in the hippocampus with long
term PM2.5 exposure (10 months) [20]. However, the re-
sults in the present study suggest that exposure even over
a few weeks is sufficient to induce increase in TNFα and
IL-6 and reactive gliosis in the medial basal hypothalamus.
In this regard, the hypothalamus may be particularly
vulnerable to the effects of diet and environmental signals
such as PM2.5 because the blood brain barrier is relatively
permeable in this part of the brain.
Our findings may have important implications for
















































































































Figure 8 Hypothalamic inflammatory genes and microglia in response to ICV infusion IMD-0354 in KKay mice exposed to PM2.5.
A, mRNA for proinflammatory cytokines (TNFα and IL-6) and NF-κB pathway (Ikkβ and IκBα) gene expression in the hypothalamus of mice exposed
to PM2.5 and treated with an IKKβ inhibitor for 4 weeks. B, Immunohistochemical detection of Iba1 protein, a microglial marker. Representative
photomicrographs captured at 20X from KKay mice treated with vehicle or received IKKβ inhibitor (bar = 50 μm). ARC microglia cell number was
quantified and normalized to each visual field. C, Representative image (40X) of microglial fine structure in the hypothalamus of vehicle-treated
mice exposed to FA and PM2.5 (bar = 50 μm). Mean microglia size was quantified by average number of pixels in 5 representative cells. Data are
expressed as mean ± SEM. *P < 0.05 compared to FA-CON group, #P < 0.05 when compared with PM-CON group. n = 7-8 per group.
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http://www.particleandfibretoxicology.com/content/11/1/53peripheral metabolic dysfunction. Examining inflamma-
tion in hypothalamus, even earlier (within the first sev-
eral days of PM2.5 inhalation), would help to clarify the
initiating role of central inflammation in the genesis of
IR. PM2.5 has been shown to permeate the CNS via
translocation along the olfactory nerve into the olfactory
bulb and exert direct effects on CNS inflammation
[19,42]. Alternatively, PM2.5 exposure may directly affectvagal afferents that may play an important role in modula-
tion of pathways that affect cardiovascular and/or peripheral
inflammatory responses [43]. As alterations in hypothalamic
signaling induced by overnutrition (particularly hypothal-
amic leptin resistance) has been demonstrated to alter sym-
pathetic outflow, this mechanism could also help couple
sympathetic activation with systemic IR [44-46]. In
































A   B
Figure 9 Hypothalamic astrocytes in response to intracerebroventricular infusion of IMD-0354 in KKay mice exposed to PM2.5.
A, Representative images (10X) of astrocytes identified by immunohistochemical detection of GFAP protein in the hypothalamus of PM2.5-exposed
mice treated with IKKβ inhibitor. The bar = 50 μm. B, Quantification of GFAP staining intensity in the ARC. Data are expressed as mean ± SEM, *P < 0.05
when compared with FA-CON group.
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activation of these cells, thus linking the alterations in
neural function with peripheral inflammation [47].
However, additional studies are required to characterize
the precise pathways.
In light of the importance of hypothalamic TNFα in
response to high fat diet [10] and our own results of the
increased TNFα, we hypothesized that this cytokine may
play a role in PM2.5-mediated IR and that its inhibition may
prevent progression of IR in the KKay model. However,
TNFα blockade at the dosage used in the study did not
antagonize the adverse effects of PM2.5 on glucose metabol-
ism and energy homeostasis. Our results are however
contrary to reports showing that central TNFα administra-
tion reduced the expression of thermogenic proteins in
brown adipose tissue and skeletal muscle, effects that were
blunted in TNFα receptor knockout mice [16,48]. Depend-
ing on its local concentrations, TNFα can exert dual func-
tions in the hypothalamus, being catabolic at high and
anabolic at low concentrations. Consistent with these diver-
gent effects on energy metabolism, TNFα levels in obese
animals are higher than that in control rats but significantly
lower than that in tumor-bearing rats. These effects were
accompanied by inhibition of feeding/anorexia in tumor-
bearing, and increase in feeding (orexigenic effect) in obese
animals respectively [16]. It is attractive to propose that the
effect of infliximab, is a reflection of the paradoxical, con-
centration dependent effect of TNFα on metabolism.
In contrast, antagonism of IKKβ, the enzyme regulating
cytokine production, completely corrected PM2.5-induced
dysfunction of glucose homeostasis. These effects are con-
sistent with a role for NFκB activation via toll-like receptor
mechanisms in response to oxPAPC generated by PM2.5 as
previously demonstrated by us [23]. This mechanism while
applicable to PM2.5, may potentially apply to other situationsincluding high-fat feeding. Consistent with this, Zhang
et al. have previously demonstrated increased expression
and activation of hypothalamic IKKβ/NF-κB in obesity,
both in leptin-deficient ob/ob mice fed a normal chow
and in high fat diet-induced obese animals [15]. These
results suggest that hypothalamic IKKβ but not TNFα is
important in PM2.5-mediated peripheral effects and
suggest a role for TLR pathways (at least not TNFα)
pathways in PM2.5 mediated peripheral effects.
Although our results suggest an important role for
CNS inflammation via IKKβ in PM2.5-mediated diabetes
development, several questions remain. Firstly, it is not
known which cell type(s) are involved in the initiation of
PM2.5-induced inflammatory responses in hypothalamus.
Although evidence suggests that IKKβ/NF-κB in specific
neuronal populations is critical to high fat diet-induced
inflammation and IR, the precise cell type and the role
of microglial cells remain unclear [15,49]. Secondly, the
specific components of PM2.5 that mediate these effects re-
main to be defined. We have provided detailed analysis on
components such as trace elements in prior studies [32,50]
as well as organic carbon fraction in this study (Figure 1).
We however submit that source apportionment type ana-
lysis is clearly beyond the scope of this paper. Thirdly, we
can not exclude direct off target systemic effects with the
pharmacological inhibitor of IKKβ by ICV in the study. To
further confirm the hypothesis, targeted deletion of IKKβ,
either with direct intra-nuclear injection into the arcuate
nucleus of adenovirus expressing dominant negative IKKβ
or cre-recombinase in conditionally expressed models will
be required. However, considering that the dose used in
the present study (600 ng/day ICV) was about 1,000-fold
lower than that used when peripherally administered (10–
20 mg/kg), it is unlikely that the effects seen in this study
are occurring secondary to systemic spill-over [51]. So,
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tribute to systemic effects. Fourthly, the precise upstream
pathways leading to the activation of IKKβ and the precise
molecular instigators of IKK-β activation remain to be
determined.
In summary, our results suggest an important role for
PM2.5-induced hypothalamic inflammation in modulating
susceptibility to Type II DM. Given the importance of air
pollution as a mediator of global morbidity and mortality,
its continuous and omnipresent nature, even small adverse
health associations for individuals may have profound
public health implications on a global scale [1,2].
Methods
Animals and animal care
KKay mice of 5-week-old or 7-week-old were purchased
from Jackson Laboratories (Bar Harbor, Me). All mice
were maintained at 21°C on a 12-h light/12-h dark cycle
with free access to water and food. The protocols and
the use of animals were approved by and in accordance
with the Ohio State University Animal Care and Use
Committee. The animals were treated humanely and
with regard for alleviation of suffering.
Ambient whole-body inhalational protocol and groups
There were three distinct exposure periods, Exposure 1,
Exposure 2, and Exposure 3. During the exposure periods,
KKay mice were exposed by inhalation to either FA or
concentrated ambient PM2.5 with 2 different exposure sys-
tems (“Ohio Air Pollution Exposure System for Interroga-
tion of Systemic Effects”) located either at the Ohio State
University Laboratory Animal Center (LAC) Facility in
Godown Road Columbus (urban exposure facility, not
proximal to a major roadway) or at the Polaris Facility (near
roadway facility located within 250 m of a major interstate
highway). Exposure 1 was conducted in LAC while Expos-
ure 2 and 3 were conducted in Polaris Facility. For Expos-
ure 1 (mice were exposed for 6 h/d, 5 d/wk, 5 weeks or
8 weeks. For Exposure 2, mice were treated (ICV) with
infliximab or artificial CSF through an implanted ICV
catheter (see ICV drug infusion protocol) and exposed for
6 h/d, 5 d/wk, for 5 weeks. For Exposure 3, mice were
treated (ICV) with IMD-0354 or vehicle of DMSO and ex-
posed for 6 h/d, 5 d/wk, for 4 weeks. For ease of identifica-
tion, the animal groups were named 5WK-FA, 5WK-PM,
8WK-FA and 8WK-PM during Exposure 1 (n = 7-8/group);
FA-CON and PM-CON (ICV with aCSF), FA-Inflix and
PM-Inflix (ICV with TNFα antibody, Infliximab, Remi-
caded), during Exposure 2 (n = 6/group); FA-CON and
PM-CON (ICV with vehicle of DMSO), FA-IMD and PM-
IMD (ICV with IKKβ inhibitor, IMD-0354, Sigma) during
Exposure 3 (n = 8 for each group). Animal exposure and
monitoring of the exposure environment and ambient aero-
sol were performed as previously described [5,36].PM2.5 concentration in the exposure chamber
To calculate exposure mass concentrations of concentrated
ambient PM2.5 in the exposure chambers, samples were
collected on Teflon filters (PTFE, 37 mm, 2 μm pore; PALL
Life Sciences, Ann Arbor, MI) and weighed before and after
sampling in a temperature- and humidity-controlled weigh-
ing room using a Mettler Toledo Excellence Plus XP
microbalance. Weight gains were used to calculate expos-
ure concentrations.ICV drug infusion
A stereotaxic apparatus was used to implant a cannula into
the right lateral ventricle of mice anesthetized with 2%
isoflurane in air. Cannula positions were +0.02 posterior
and −0.95 lateral to Bregma, extending 2.75 mm below the
skull (Plastics One, Roanoke, VA). The cannula was con-
nected via tubing to an Alzet minipump (Model 1004,
Durect, Cupertino, CA) that was implanted subcutaneously
in the scapular region and delivered either drugs (Infliximab
and IMD 0354) or vehicles, both at a rate of 0.11 μL/h.
Minipumps were implanted 1 day prior to initiation of
either PM2.5 or FA exposure. The infliximab-treated groups
received a total of 0.2 μg of the antibody, and the IMD-
0354-treated groups received a total of 600 ng of the
inhibitor per day. Cannula placement was verified in tissue
used for immunohistochemistry.Measurements of blood glucose homeostasis and insulin
sensitivity
Before and subsequent to the exposure to FA or PM2.5,
mice were fasted overnight and dextrose (2 mg/g body
weight) was injected intra-peritoneally for intra-peritoneal
glucose tolerance testing (IPGTT). Blood sample was
collected from the vena caudalis and blood glucose meas-
urement was conducted with an Contour Blood Glucose
Meter (Bayer, Mishawaka, IN) at baseline, and 30, 60, 90,
and 120 minutes after the dextrose injection. During the
exposure period, 6 h-fasting blood glucose was monitored
every week, with the same glucose meter as GTT. Insulin
levels were determined using an Ultra Sensitive Mouse
Insulin ELISA Kit (Crystal Chem Inc., Downers Grove,
IL). HOMA-IR were calculated based on 1 mg of insulin
as equivalent to 24 IU, using the formula HOMA= [fast-
ing insulin concentration (ng/ml) × 24 × fasting glucose
concentration (mg/dl)]/405 [36].
By the end of exposure, insulin sensitivity was measured
by the insulin tolerance test (ITT). After 4.5 hours fasting,
Insulin (0.5 U/kg) was administered by intra-peritoneal in-
jection. Blood glucose measurement was conducted in the
same way as IPGTT with the same Contour Blood Glu-
cose Meter at baseline, and 30, 60, 90, and 120 minutes
after insulin injection.
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The mice were isolated in a semi-sealed cage, and the inner
air was aspirated at a constant volume/min. Oxygen con-
sumption, CO2 production, respiratory exchanging ratio
and heat production were measured simultaneously using a
computer-controlled, open-circuit Oxymax/CLAMS Sys-
tem (Columbus Instruments, Columbus, OH). Each mouse
was measured individually in a resting state at 22°C in the
presence of food and water [52]. Measurements were taken
for a 24-h period, including a 12-h light cycle and a 12-h
dark cycle. Data were normalized to body weight.
Flow cytometric evaluation of inflammation in
blood/tissues
Visceral adipose tissues from the mice were excised,
minced, and digested with collagenase type II, and the SVF
isolated as described previously.These cells were centri-
fuged at 500 × g for 5 min. Whole blood was centrifuged at
500 × g, 4°C for 5 min and plasma was collected. The
remaining blood cells and the resulting pellets were re-
suspended in 1X red blood cell lysis buffer (Biolegend, San
Diego, CA), at room temperature for 3 minutes followed by
addition of 1 X PBS and centrifugation. Then, blood cells
spleen cells and bone marrow derived cells were stained
with anti-CD11b, anti-7/4 and anti-Gr-1, SVFs were stained
with anti-CD11c and F4/80, both followed by incubation at
room temperature for 45 minutes. Cells were subsequently
washed with 1 X PBS and re-suspended in 1% neutral buff-
ered formalin and run by flow cytometry (BD FACS LSR
II™ flow cytometer, Becton Dickinson, San Jose, CA). Data
was analyzed using BD FACS Diva software (Becton
Dickinson, San Jose, CA). All antibodies were purchased
from Biolegend, Miltenyi Biotec, or BD Bioscience [23,53].
Immunohistochemistry
Mice were perfused transcardially with ice-cold 0.1M PBS.
Brains were removed, divided at the hemisphere with a
sterile razor, and the right hemisphere was fixed overnight
in 4% paraformaldehyde. The half brains were subsequently
cyroprotected in 30% sucrose, frozen in isopentane with
dry ice, and stored at −80°C. Eighteen μm brain sections
were sliced at −22°C using a cryostat, thaw mounted onto
Super Frost Plus slides (Fisher, Hampton, NH), and stored
at −20°C. The sections were rinsed in PBS and blocked with
4% BSA in PBS +Triton-X (TX) for 1 h with constant agita-
tion. Alternate slides were incubated overnight with rabbit
anti-Iba-1 (1:1000, Wako Chemicals, Richmond, VA), rabbit
anti-GFAP (1:1000, abcam, Cambridge, MA) or rabbit anti-
POMC (1:4000; Pheonix Pharmaceuticals, Burligame, CA).
After PBS rinses the slides were subsequently incubated for
1 h at room temperature with biotinylated goat-anti-rabbit
1:1000 in PBS +TX (Vector Laboratories, Burligame, CA).
Sections were then quenched for 20 min in methanol
containing 0.3% hydrogen peroxide. After washing withPBS, sections were incubated for 1 h with avidin-biotin com-
plex (ABC Elite kit, Vector laboratories). After rinses the sec-
tions were developed in diaminobenzidine for ~2 min
(Sigma, D4168), rinsed, and immediately dehydrated and
coverslipped with Permount. Images were captured on a
Nikon E800 microscope and analyzed using Image J soft-
ware (NIH) to determine immunoreactive regions. For the
GFAP densitometry analysis and microglia counts 2 sections
were used per mouse and averaged to generate a single
value. To establish the relative microglial size, 6 representa-
tive microglia were selected per animal for pixel count and
also averaged to generate a single value.
Quantitative RT-PCR
RT-PCR was performed using RNA extracted from hypo-
thalamus of the experimental mice. After brains were re-
moved, the left brain hemisphere was placed in RNAlater.
The hypothalamus was subsequently removed and total
RNA was extracted using a homogenizer (Ultra-Turrax
T8, IKAWorks, Wilmington, NC) and an RNeasy Mini
Kit (Qiagen, Austin, TX) according to manufacturer in-
structions. RNA was then reverse transcribed into cDNA
with M-MLV Reverse Transcriptase enzyme (Invitrogen,
Carlsbad, CA). Gene expression for TNFα, IL6, SOCS3,
Ikbkb, Nfkbia, MAC1 and POMC were determined
using inventoried primer and probe assays (Applied
Biosystems, Foster City, CA) on an ABI 7500 Fast Real
Time PCR System using Taqman® Universal PCR
Master Mix. The universal two-step RT-PCR cycling
conditions used were: 50°C for 2 min, 95°C for 10 min,
followed by 40 cycles of 95°C for 15 s and 60°C for
1 min. Relative gene expression of individual samples
run in duplicate was calculated by comparison to a
relative standard curve and standardized by comparison
to 18S rRNA signal.
Liquid chromatography mass spectrometry of oxidized
phospholipids
Lipids from brain of mice exposed to FA or PM2.5 were
extracted three times with chloroform/methanol mixture
(1:1) and combined extracts were evaporated to dryness
under stream of nitrogen. Samples were stored under nitro-
gen atmosphere at −80°C until analysis. Mass spectra were
acquired in positive ion mode using Applied Biosystems
3200 QTRAP system coupled with electrospray ionization
(TurbolonSpray) source. The spectrometer was optimized
by infusion of PAPC (25 nmol/ml) and POVPC (5 nmol/
ml). All phospholipids were purchased from Avanti Polar
Lipids Inc, (Alabaster, AL). The source parameters were
set as follows: curtain gas (nitrogen), 10 psi; collision gas
(nitrogen), medium; ion spray voltage 5000 V; temperature
550°C, ion spray voltage, 5000 V; ion source gas 1 and 2, 30
and 50 psi, respectively. Optimized parameters for all
phospholipids were: declustering potential, 50 V; entrance
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brain extracts, samples were dissolved in mobile phase
consisting of chloroform, methanol, water and trifluoroace-
tic acid (65:25:4:0.1, by vol). Lipids were characterized after
isocratic separation on 5 m Zorbax RX-SIL 4.6 mm ×
250 mm HPLC column (Agilent Technologies, Santa Clara,
CA) at 0.4 ml/min flow rate using Shimadzu LC-20 AD
pump interfaced to a Shimadzu CBM-20A system control-
ler. Mass spectrometer was operated in multiple reactions
monitoring (MRM) positive ionization mode. Specific
monitor Q1/Q3 ion pairs were m/z 782184 for PAPC and
m/z 594184 for POVPC. Standard curves for all phospho-
lipids were obtained in the same set of experiments by infu-
sion of serially diluted PAPC and POVPC. All data were
acquired and processed by Analyst software (version 1.4.2,
Applied Biosystems, Foster City, CA).Data analysis
Data are expressed as means ± standard error of the mean
unless otherwise indicated. For the analysis of hypothalamic
inflammation biomarkers, linear regression was used with
PM exposure, treatment group, and PM x treatment inter-
action as the independent variables. Based on our previous
studies, we had an a priori hypothesis regarding the direc-
tion of the outcome. A one-tailed t-test was used to analyze
the effect of 5-week or 8-week PM exposure on mRNA
expression in hypothalamus. To examine the effect of PM
exposure on glucose homeostasis, body weight, and food
intake in each treatment group (PM and FA), a stratified
analysis using linear regression (with PM exposure, treat-
ment group, and their interaction) was initially performed
at each time point of measurement. In addition, an overall
repeated measures analysis was performed using all obser-
vations with covariates in the linear model: PM, treatment
group, PM x treatment interaction, and time. For body
weight and food intake, the analysis further adjusted for
baseline measures (0 week) when available. For the mea-
surements on energy metabolism/expenditure response,
two analysis strategies were used - (1) taking the average
over time (cycles) for each mouse and then using linear re-
gression and (2) using repeated measures analysis, adjusting
for time. For all repeated measures analyses, in each model
a correlation structure was chosen based on the Akaike
Information Criterion (AIC) value to account for the
correlation between repeated measurements on the same
mouse or mice staying in the same cage. A p-value of
less than 0.05 was deemed statistically significant. All
analyses were performed using R2.15.0.
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